130 related articles for article (PubMed ID: 38416315)
21. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
Wang H; Wang X; Wang CF
Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.
Lv S; Niu Y; Wei L; Liu Q; Wang X; Chen Y
Breast Cancer Res Treat; 2008 Dec; 112(3):411-8. PubMed ID: 18189161
[TBL] [Abstract][Full Text] [Related]
23. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
24. Real-world data on malignant and borderline phyllodes tumors of the breast: A population-based study of all 921 cases in the Netherlands (1989 -2020).
Bartels SAL; van Olmen JP; Scholten AN; Bekers EM; Drukker CA; Vrancken Peeters MTFD; van Duijnhoven FH
Eur J Cancer; 2024 Apr; 201():113924. PubMed ID: 38364628
[TBL] [Abstract][Full Text] [Related]
25. Karyotypic changes in phyllodes tumors of the breast.
Dietrich CU; Pandis N; Bardi G; Teixeira MR; Soukhikh T; Petersson C; Andersen JA; Heim S
Cancer Genet Cytogenet; 1994 Dec; 78(2):200-6. PubMed ID: 7828153
[TBL] [Abstract][Full Text] [Related]
26. Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists.
Sars C; Sackey H; Frisell J; Dickman PW; Karlsson F; Kindts I; Marta GN; Freitas-Junior R; Tvedskov TF; Kassem L; Ali AS; Ihalainen H; Neron M; Kontos M; Kaidar-Person O; Meattini I; Francken AB; van Duijnhoven F; Moberg IO; Marinko T; Kollar A; Ahmed M; Remoundos D; Banks J; Jagsi R; Dossett LA; Lindqvist EK
Breast Cancer Res Treat; 2023 Jun; 199(2):293-304. PubMed ID: 36879102
[TBL] [Abstract][Full Text] [Related]
27. Five-Year Disease-Free Follow-Up of a Borderline Breast Phyllodes Tumor in a 15-year-old Patient.
Güler SA; Uğurlu MÜ; Güllüoğlu BM
J Breast Health; 2015 Jul; 11(3):138-140. PubMed ID: 28331709
[TBL] [Abstract][Full Text] [Related]
28. Local recurrence after breast-conserving therapy for phyllodes tumors: A 15-year retrospective review.
Cervoni GE; Quintana L; Erlinger AL; Neo DT; Recht A; Schnitt SJ; Hacker MR; Sharma R
Breast J; 2020 May; 26(5):988-990. PubMed ID: 31814215
[TBL] [Abstract][Full Text] [Related]
29. Phyllodes Tumors of the Breast (the Egyptian Experience).
Ibreaheem MH; Naguib S; Gamal M; Boutrus R; Gomaa MMM; Talaat O
Indian J Surg Oncol; 2020 Sep; 11(3):423-432. PubMed ID: 33013122
[TBL] [Abstract][Full Text] [Related]
30. Re-Classification with Outcome Correlation of Previously Diagnosed Malignant Phyllodes Tumors Applying the 2016 Consensus Guidelines.
Duckworth LA; Hoda R; Komforti MK; Rowe JJ; Downs-Kelly E; McIntire PJ
Int J Surg Pathol; 2023 Aug; 31(5):557-563. PubMed ID: 35786083
[No Abstract] [Full Text] [Related]
31. [Prognosis analysis of local recurrence after excision of breast phyllodes tumors].
Peng Y; Zhang YY; Wang SC; Wu JB; Tong FZ; Liu P; Cao YM; Zhou B; Cheng L; Liu M; Liu HJ; Guo JJ; Xie F; Yang HP; Wang SY; Wang CB; Wang S
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):116-120. PubMed ID: 33378803
[No Abstract] [Full Text] [Related]
32. [Treatment of phyllodes tumours of the breast: evaluation of 66 cases and literature review].
Lohmeyer JA; Huster N; Lühr C; Lindner C; Wittig KS; Keck MK
Handchir Mikrochir Plast Chir; 2021 Apr; 53(2):159-167. PubMed ID: 32785910
[TBL] [Abstract][Full Text] [Related]
33. Management of non metastatic phyllodes tumors of the breast: review of the literature.
Khosravi-Shahi P
Surg Oncol; 2011 Dec; 20(4):e143-8. PubMed ID: 21609854
[TBL] [Abstract][Full Text] [Related]
34. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
[TBL] [Abstract][Full Text] [Related]
36. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
[TBL] [Abstract][Full Text] [Related]
37. Factors effective on recurrence and metastasis in phyllodes tumors.
Altiok M; Kurt F
Niger J Clin Pract; 2022 Apr; 25(4):425-431. PubMed ID: 35439900
[TBL] [Abstract][Full Text] [Related]
38. Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence.
Yu CY; Huang TW; Tam KW
Int J Surg; 2022 Nov; 107():106969. PubMed ID: 36328344
[TBL] [Abstract][Full Text] [Related]
39. Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors.
Moo TA; Alabdulkareem H; Tam A; Fontanet C; Lu Y; Landers A; D'Alfonso T; Simmons R
Ann Surg Oncol; 2017 Oct; 24(10):3088-3092. PubMed ID: 28766221
[TBL] [Abstract][Full Text] [Related]
40. Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.
Demian GA; Fayaz S; El-Sayed Eissa H; Nazmy N; Samir S; George T; El-Sherify M; Abuzalouf S
J Egypt Natl Canc Inst; 2016 Dec; 28(4):243-248. PubMed ID: 27406381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
